Zolpidem, also known as Ambien, is a hypnotic drug that was initially approved by the FDA in 1992 . Zolpidem improves sleep in patients with insomnia. It is aimed for use in patients with difficulties initiating sleep. This drug decreases the time to fall asleep (sleep latency), increases the duration of sleep, and decreases the number of awakenings during s...
This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation .
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.